Technosphere insulin
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 1
Conditions
Diabetes Mellitus, Type 1
Trial Timeline
Sep 30, 2017 → Jan 31, 2018
NCT ID
NCT03143816About Technosphere insulin
Technosphere insulin is a approved stage product being developed by MannKind Corp for Diabetes Mellitus, Type 1. The current trial status is completed. This product is registered under clinical trial identifier NCT03143816. Target conditions include Diabetes Mellitus, Type 1.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Type 1 were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03143816 | Approved | Completed |
| NCT00642681 | Pre-clinical | Completed |
| NCT00570687 | Phase 2 | Completed |
| NCT00332826 | Phase 3 | Terminated |
| NCT00539890 | Phase 3 | Completed |
| NCT00539396 | Phase 2 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 1